[go: up one dir, main page]

DE60028248D1 - Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen - Google Patents

Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen

Info

Publication number
DE60028248D1
DE60028248D1 DE60028248T DE60028248T DE60028248D1 DE 60028248 D1 DE60028248 D1 DE 60028248D1 DE 60028248 T DE60028248 T DE 60028248T DE 60028248 T DE60028248 T DE 60028248T DE 60028248 D1 DE60028248 D1 DE 60028248D1
Authority
DE
Germany
Prior art keywords
amino acid
acid sequence
immunogenicity
protein
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60028248T
Other languages
English (en)
Other versions
DE60028248T2 (de
Inventor
Adriana Warmerdam
Daniel Plaisance
Jose Collen
Maeyer Cyriel De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thromb X NV
Original Assignee
Thromb X NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thromb X NV filed Critical Thromb X NV
Publication of DE60028248D1 publication Critical patent/DE60028248D1/de
Application granted granted Critical
Publication of DE60028248T2 publication Critical patent/DE60028248T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60028248T 1999-12-02 2000-12-01 Verfahren zur Reduzierung der Immunogenität von Staphylokinase durch Entfernen von T-Zell-Epitopen Expired - Fee Related DE60028248T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204093 1999-12-02
EP99204093 1999-12-02
PCT/EP2000/012299 WO2001040281A2 (en) 1999-12-02 2000-12-01 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes

Publications (2)

Publication Number Publication Date
DE60028248D1 true DE60028248D1 (de) 2006-06-29
DE60028248T2 DE60028248T2 (de) 2007-03-15

Family

ID=8240963

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028248T Expired - Fee Related DE60028248T2 (de) 1999-12-02 2000-12-01 Verfahren zur Reduzierung der Immunogenität von Staphylokinase durch Entfernen von T-Zell-Epitopen

Country Status (7)

Country Link
US (1) US20030134335A1 (de)
EP (1) EP1252183B1 (de)
CN (1) CN100335498C (de)
AT (1) ATE327251T1 (de)
AU (1) AU2363301A (de)
DE (1) DE60028248T2 (de)
WO (1) WO2001040281A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096454A1 (en) * 2001-05-31 2002-12-05 D. Collen Research Foundation Vzw Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
WO2002098454A2 (en) * 2001-05-31 2002-12-12 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
US20040209312A1 (en) * 2001-11-13 2004-10-21 Harding Fiona A Identifying and reducing the allergenicity of food proteins
US20040018568A1 (en) * 2002-07-23 2004-01-29 Subhashis Banerjee Methods for detecting deantigenized T cell epitopes and uses thereof
AU2004204942A1 (en) * 2003-01-08 2004-07-29 Xencor, Inc Novel proteins with altered immunogenicity
BRPI0411127A (pt) * 2003-06-10 2006-05-23 Univ Melbourne composição de matéria para modulação de resposta imuno num sujeito a um antìgeno alvo e respectivos método de modulação, processo de produção de células de apresentação de antìgeno e método de tratamento e/ou profilaxia de doença ou condição associada à presença de antìgeno alvo de interesse
US8452541B2 (en) * 2007-06-18 2013-05-28 Microsoft Corporation Vaccine design methodology
CA2691539C (en) 2007-06-21 2014-08-26 Angelica Therapeutics, Inc. Modified toxins
CN101848928B (zh) * 2007-10-09 2013-07-17 凝血基因公司 葡激酶变异体
EP2268297A4 (de) * 2008-02-29 2011-11-16 Angelica Therapeutics Inc Modifizierte toxine
EP2968450A4 (de) 2013-03-15 2016-10-26 Angelica Therapeutics Inc Modifizierte toxine
CN109002690B (zh) * 2018-06-08 2021-05-18 济南大学 通过构建charmm rotamers力场预测突变氨基酸侧链结构的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736549B2 (en) * 1997-05-21 2001-08-02 Merck Patent Gesellschaft Mit Beschrankter Haftung Method for the production of non-immunogenic proteins
JP2002505082A (ja) * 1998-02-04 2002-02-19 トロンブ−イックス・ナムローゼ・フェンノートシャップ 減少した免疫原性および／または減少したクリアランスを有するスタフィロキナーゼ誘導体の同定、製造および使用方法
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
ES2278463T3 (es) * 1998-12-08 2007-08-01 Biovation Limited Metodo para reducir la inmunogenicidad de proteinas.

Also Published As

Publication number Publication date
WO2001040281A2 (en) 2001-06-07
DE60028248T2 (de) 2007-03-15
EP1252183A2 (de) 2002-10-30
US20030134335A1 (en) 2003-07-17
AU2363301A (en) 2001-06-12
CN1414972A (zh) 2003-04-30
EP1252183B1 (de) 2006-05-24
CN100335498C (zh) 2007-09-05
WO2001040281A3 (en) 2001-12-20
ATE327251T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
ATE352559T1 (de) Verfahren zur verminderung der immunogenität von proteinen
ATE468127T1 (de) Ii-key/antigene epitop-hybrid-peptid-vakzine
DE60028248D1 (de) Methode zur reduzierung der immunogenizität von staphylokinase durch entfernen von t-zell epitopen
ATE277198T1 (de) Verfahren zur in vitro evolution von proteinfunktionen
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
DK1513937T3 (da) Fremgangsmåde til den samtidige produktion af multiple proteiner; vektorer og celler til anvendelse derved
RU98118184A (ru) Пептидные иммуногены для вакцинации и лечения аллергии
CY1111831T1 (el) Παραγωγα ογκο-συναφους αντιγονου απο την οικογενεια mage και αλληλουχιες νουκλεϊνικου οξεος που κωδικοποιουν αυτα, που χρησιμοποιουνται για την παρασκευη πρωτεϊνων συντηξης και συνθεσεων για εμβολιασμο
DE69534374D1 (de) Methoden und zubehör zur immunisierung von wirtsorganismen durch verabreichung nackter polynucleotide , welche für antigene peptide codieren
RU2008120299A (ru) СПОСОБЫ ПОЛУЧЕНИЯ КОМПОЗИЦИЙ, ВКЛЮЧАЮЩИХ ХИТШОКОВЫЕ БЕЛКИ ИЛИ α-2-МАКРОГЛОБУЛИН, ПРИГОДНЫХ ДЛЯ ЛЕЧЕНИЯ ЗЛОКАЧЕСТВЕННОЙ ОПУХОЛИ И ИНФЕКЦИОННОГО ЗАБОЛЕВАНИЯ
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
DK1904529T3 (da) Anvendelse af Stefin A som et scaffoldprotein
DE59509642D1 (de) Verfahren zur modifizierung der stabilität von antikörpern
EA200401504A1 (ru) Слитый белок из числа регуляторных/вспомогательных белков вич
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
DE69434413D1 (de) Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin
ATE130102T1 (de) Verfahren zur identifizierung oder bestimmung von proteinen und verwendungen dazu.
NZ592340A (en) A method for making a virus vaccine compising Replikin peptides
EP1104777A1 (de) Gelatin und ein Verfahren zu dessen Herstellung
ATE473755T1 (de) Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 large t antigen mit einem intakten n terminus
ATE439368T1 (de) Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung
WO2002073209A3 (de) Verfahren zur identifikation von immunreaktiven epitopen auf proteinen
ATE112290T1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
DE59005082D1 (de) Antikörper gegen hochkonservierte Aminosäuresequenzen von immunogenen Substanzen, Verfahren zur Herstellung dieser Antikörper, sowie deren Verwendung in Immunoassays.
EP1310512A3 (de) HCV-Kernprotein-Sequenzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee